Gilead Sciences Inc (GILD) — Cash Flow Reinvestment Rate
Gilead Sciences Inc (GILD) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $3.33 Billion. See how much free cash does Gilead Sciences Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Gilead Sciences Inc Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Gilead Sciences Inc across 24 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Gilead Sciences Inc.
Annual Cash Flow Reinvestment Rate for Gilead Sciences Inc (2002–2025)
Year-by-year capital reinvestment analysis for Gilead Sciences Inc. See GILD financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $0.00 | $10.02 Billion | $0.00 | ▼ -100.0% |
| 2024 | 0.37x | $3.97 Billion | $10.83 Billion | $523.00 Million | ▲ +17.6% |
| 2023 | 0.31x | $2.50 Billion | $8.01 Billion | $585.00 Million | ▼ -11.4% |
| 2022 | 0.35x | $3.19 Billion | $9.07 Billion | $728.00 Million | ▲ +8.0% |
| 2021 | 0.33x | $3.71 Billion | $11.38 Billion | $579.00 Million | ▼ -78.9% |
| 2020 | 1.54x | $12.60 Billion | $8.17 Billion | $650.00 Million | ▲ +350.3% |
| 2019 | 0.34x | $3.13 Billion | $9.14 Billion | $825.00 Million | ▼ -82.2% |
| 2018 | 1.93x | $16.20 Billion | $8.40 Billion | $924.00 Million | ▲ +306.7% |
| 2017 | 0.47x | $5.64 Billion | $11.90 Billion | $590.00 Million | ▼ -32.5% |
| 2016 | 0.70x | $11.98 Billion | $17.05 Billion | $748.00 Million | ▲ +19.8% |
| 2015 | 0.59x | $12.47 Billion | $21.25 Billion | $747.00 Million | ▲ +312.8% |
| 2014 | 0.14x | $1.82 Billion | $12.82 Billion | $557.00 Million | ▼ -12.6% |
| 2013 | 0.16x | $505.07 Million | $3.10 Billion | $190.00 Million | ▼ -52.5% |
| 2012 | 0.34x | $1.09 Billion | $3.19 Billion | $397.00 Million | ▼ -71.9% |
| 2011 | 1.22x | $4.44 Billion | $3.64 Billion | $131.90 Million | ▲ +87.3% |
| 2010 | 0.65x | $1.85 Billion | $2.83 Billion | $61.88 Million | ▲ +107.3% |
| 2009 | 0.31x | $968.08 Million | $3.08 Billion | $230.06 Million | ▲ +485.8% |
| 2008 | 0.05x | $115.00 Million | $2.14 Billion | $115.00 Million | ▲ +20.4% |
| 2007 | 0.04x | $78.65 Million | $1.77 Billion | $78.65 Million | ▼ -48.4% |
| 2006 | 0.09x | $105.21 Million | $1.22 Billion | $105.21 Million | ▲ +27.1% |
| 2005 | 0.07x | $47.95 Million | $705.64 Million | $47.95 Million | ▼ -32.8% |
| 2004 | 0.10x | $51.37 Million | $507.96 Million | $51.37 Million | ▼ -38.6% |
| 2003 | 0.16x | $38.61 Million | $234.61 Million | $38.61 Million | ▼ -30.4% |
| 2002 | 0.24x | $17.60 Million | $74.41 Million | $17.60 Million | — |